Janssen Pharmaceutica Nv

Janssen Sciences Ireland Unlimited Company

Wing Shun Cheung

Qian Liu

Zhao-Kui Wan

Haibing Guo

Luoheng Qin

Yimin Jiang

Gang Deng

Yanping Xu

Zhanling Cheng

Chao Liang

Liqiang Fu

Xuedong Dai

Pyrazolopyridinone compounds, the pharmaceutical compositions comprising said compounds, and the use of said compounds as FGFR (fibroblast growth factor receptor) inhibitors and their use in the treatment of diseases, e.g. cancer.

Pyrazolopyridinone compounds

Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject, and the compound has the structure of Formula I including any possible deuterated isomers, stereoisomers or tautomeric forms thereof.

Heteroaryldihydropyrimidine derivatives and methods of treating hepatitis B infections

The invention relates to new quinolinone compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds as FGFR (fibroblast growth factor receptor) inhibitors and to their use in the treatment of diseases, e.g. cancer.

Quinolinone compounds

The application describes dihydropyrimidine derivatives which are useful in the treatment or prevention of HBV infection or of HBV-induced diseases, more particularly of HBV chronic infection or of diseases induced by HBV chronic infection, as well as pharmaceutical or medical applications thereof.

Substituted 1,4-dihydropyrimidines for the treatment of HBV infection or HBV-induced diseases

Growing community of inventors

Shanghai, China

Wing Shun Cheung